24 June, 2017
Ltd. now owns 2,801,318 shares of the company's stock valued at $175,449,000 after buying an additional 2,311,080 shares in the last quarter. Time Warner Inc now has $77.27 billion valuation. The stock rose 0.22% or $0.16 reaching $73.34. About 729,008 shares traded. It is down 10.63% since June 23, 2016 and is uptrending. It has outperformed by 3.47% the S&P500. Therefore 56% are positive. Abbvie Inc had 37 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of AbbVie Inc (NYSE:ABBV) has "Buy" rating given on Friday, March 10 by Goldman Sachs. The firm has "Sector Perform" rating given on Friday, July 22 by RBC Capital Markets. The company was upgraded on Monday, September 28 by Citigroup. On September 8, 2016 the stock rating was changed to a "Neutral" in a report from JP Morgan a cut from the previous "Outperform" rating. Jefferies maintained the shares of ABBV in report on Thursday, May 25 with "Buy" rating. The company was maintained on Friday, October 23 by UBS. Raymond James upgraded the shares of MYL in report on Monday, October 10 to "Strong Buy" rating. BMO Capital Markets maintained AbbVie Inc (NYSE:ABBV) rating on Friday, April 28.
Since February 28, 2017, it had 0 insider buys, and 10 selling transactions for $28.02 million activity. Also, CFO William J. Chase sold 38,300 shares of the company's stock in a transaction on Thursday, May 18th.
In other AbbVie news, EVP Carlos Alban sold 43,000 shares of the company's stock in a transaction on Thursday, May 4th. 22,451 shares were sold by RICHMOND TIMOTHY J., worth $1.47 million on Friday, March 10. The insider ANDERSON BRIAN P sold 14,000 shares worth $324,520. 79,800 AbbVie Inc (NYSE:ABBV) shares with value of $5.59M were sold by Schumacher Laura J. Insiders sold a total of 278,135 shares of company stock worth $18,841,085 in the last ninety days.
On last trading day, Intrexon Corporation (NYSE:XON) traded 1.23 Million shares and was closed at $25.29 per share.
Investors sentiment decreased to 0.79 in Q4 2016. Its down 0.02, from 0.13 in 2016Q3. It turned negative, as 86 investors sold ABBV shares while 555 reduced holdings. 3 funds opened positions while 1 raised stakes. Ubs Asset Mngmt Americas holds 5.42 million shares or 0.38% of its portfolio. $143,031 worth of AbbVie Inc (NYSE:ABBV) shares were sold by HURWICH THOMAS A. Ledyard National Bank's holdings in AbbVie were worth $1,198,000 at the end of the most recent reporting period. Stockholders of record on Friday, July 14th will be given a dividend of $0.64 per share. The MAA evaluation is conducted under the centralized licensing procedure, and if approved, will result in a marketing authorization valid in all 28 member states of the European Union, as well as Iceland, Liechtenstein and Norway.
More notable recent AbbVie Inc (NYSE:ABBV) news were published by: Seekingalpha.com which released: "AbbVie: A Wonderful Company But At What Price?" on June 21, 2017, also Fool.com with their article: "Better Buy: Pfizer Inc. vs. AbbVie Inc." published on June 20, 2017, Seekingalpha.com published: "Abbvie Vaults First Pivotal Hurdle With Oral RA Candidate" on June 09, 2017. Tarbox Grp Inc holds 53,675 shares. "(ABBV) Shares Bought by Bollard Group LLC" was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. Stifel Financial accumulated 2.93 million shares. 146,756 were reported by Hendershot Investments Incorporated. Dock Street Asset Management Inc holds 59,969 shares or 2.02% of its portfolio. Blair William & Co Il holds 0.41% or 731,337 shares in its portfolio. Virtu Fincl Limited Liability Corp invested 0.07% in AbbVie Inc (NYSE:ABBV). It also reduced Novan Inc stake by 76,381 shares and now owns 341,628 shares. Bank Of Nova Scotia (NYSE:BNS) was reduced too.
Among 17 analysts covering Mylan Inc.
Among 5 analysts covering The Jean Coutu Group (TSE:PJC.A), 0 have Buy rating, 2 Sell and 3 Hold. Therefore 83% are positive. Vetr raised shares of AbbVie from a "buy" rating to a "strong-buy" rating and set a $74.38 target price on the stock in a research note on Monday, May 8th. Credit Suisse maintained it with "Hold" rating and $65 target in Wednesday, June 7 report. BMO Capital Markets has "Hold" rating and $63 target. The company was maintained on Thursday, December 22 by FBR Capital. The firm has "Overweight" rating given on Monday, November 2 by Morgan Stanley. M Partners maintained Time Warner Inc (NYSE:TWX) rating on Friday, November 27. AbbVie now has an average rating of "Buy" and a consensus target price of $73.27.
Partner Fund Management Lp decreased Vipshop Hldgs Ltd stake by 29.92 million shares to 29.58M valued at $29.61 million in 2016Q4.
Investors sentiment decreased to 0.98 in Q4 2016. Its up 0.07, from 1.02 in 2016Q3. Gmt Corporation invested in 443,400 shares or 0.35% of the stock. 57 funds opened positions while 102 raised stakes. Cullen Frost Bankers reported 491,097 shares or 1.06% of all its holdings. House Ltd Com invested in 0.98% or 102,556 shares. Massachusetts-based Braver Wealth Mgmt Llc has invested 1.03% in AbbVie Inc (NYSE:ABBV). Rhumbline Advisers reported 0.39% in AbbVie Inc (NYSE:ABBV). Com for a number of months, seems to be less bullish one the $118.31 billion market cap company. 48,853 were reported by Visionary Asset Mngmt Incorporated. Thompson Siegel & Walmsley Ltd Com owns 52,577 shares for 0.04% of their portfolio. 41,331 were accumulated by Commerzbank Aktiengesellschaft Fi. Fjarde Ap owns 71,032 shares. Blackrock reported 3.97 million shares. First Tru Advsr Lp holds 1.22M shares or 0.23% of its portfolio. More interesting news about AbbVie Inc (NYSE:ABBV) were released by: Seekingalpha.com and their article: "AbbVie: Generate 13% Annualized Yield On This Drug Maker" published on May 31, 2017 as well as Seekingalpha.com's news article titled: "What Comes After Humira?" with publication date: June 08, 2017.
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
